| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Unité de virologie humaine, ENS-INSERM, U412, Ecole Normale Supérieure de Lyon, 46 Allée d'Italie, 69364-Lyon Cedex 07, France
The Epstein—Barr Virus (EBV) gene BZLF1 encodes the transcription factor EB1 (also known as Zta) which is essential for the switch from latency to the lytic cycle: EB1 expressed from a plasmid transfected into B cell lines carrying latent EBV episomes, induces a productive viral cycle. Furthermore, EB1-specific DNA-binding sequences (ZREs) have been found in the promoters of many EBV early genes, including the BZLF1 promoter PZ and the PR promoter. At promoter PR, bicistronic mRNAs are initiated which contain, from 5' to 3', the BRLF1 and the BZLF1 open reading frames (ORFs) encoding respectively the R and EB1 proteins. The current model for the activation of the EBV lytic cycle implies that downregulation of the PZ promoter activity is a key element for latency and that a limiting step in the activation of the productive cycle is the translation of EB1. Once made, EB1 autoactivates promoter PZ, activates the PR promoter at which an mRNA coding for the EBV transcription factor R is initiated and activates the EBV early genes and the ORIlyt, due to unrestricted accessibility of the EB1-responsive elements in the viral genome. We show here that EB1 expressed from a plasmid activated most if not all of the EBV early genes in the viral genome but not its own gene, BZLF1. Moreover, transfected EB1 induced the transcription of the bicistronic mRNAs from which R is efficiently translated but not EB1. Our results demonstrate that EB1 provided in trans, although competent to activate the productive cycle genes, was not sufficient to overcome the downregulation of the PZ promoter.
* Author for correspondence. Fax +33 72 72 86 86. e-mail LauraCorbo@cri.ens-lyon.fr
Received 25 July 1995;
accepted 31 October 1995.
This article has been cited by other articles:
|
|
 |
|
  R. Feederle, A. M. Mehl-Lautscham, H. Bannert, and H.-J. Delecluse The Epstein-Barr Virus Protein Kinase BGLF4 and the Exonuclease BGLF5 Have Opposite Effects on the Regulation of Viral Protein Production J. Virol., November 1, 2009; 83(21): 10877 - 10891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Iwahori, T. Murata, A. Kudoh, Y. Sato, S. Nakayama, H. Isomura, T. Kanda, and T. Tsurumi Phosphorylation of p27Kip1 by Epstein-Barr Virus Protein Kinase Induces Its Degradation through SCFSkp2 Ubiquitin Ligase Actions during Viral Lytic Replication J. Biol. Chem., July 10, 2009; 284(28): 18923 - 18931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ye, L. Gradoville, D. Daigle, and G. Miller De Novo Protein Synthesis Is Required for Lytic Cycle Reactivation of Epstein-Barr Virus, but Not Kaposi's Sarcoma-Associated Herpesvirus, in Response to Histone Deacetylase Inhibitors and Protein Kinase C Agonists J. Virol., September 1, 2007; 81(17): 9279 - 9291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Guindy, L. Heston, H.-J. Delecluse, and G. Miller Phosphoacceptor Site S173 in the Regulatory Domain of Epstein-Barr Virus ZEBRA Protein Is Required for Lytic DNA Replication but Not for Activation of Viral Early Genes J. Virol., April 1, 2007; 81(7): 3303 - 3316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Heston, A. El-Guindy, J. Countryman, C. Dela Cruz, H.-J. Delecluse, and G. Miller Amino Acids in the Basic Domain of Epstein-Barr Virus ZEBRA Protein Play Distinct Roles in DNA Binding, Activation of Early Lytic Gene Expression, and Promotion of Viral DNA Replication J. Virol., September 15, 2006; 80(18): 9115 - 9133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. El-Guindy, S. Y. Paek, J. Countryman, and G. Miller Identification of Constitutive Phosphorylation Sites on the Epstein-Barr Virus ZEBRA Protein J. Biol. Chem., February 10, 2006; 281(6): 3085 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Daibata, K. Bandobashi, M. Kuroda, S. Imai, I. Miyoshi, and H. Taguchi Induction of Lytic Epstein-Barr Virus (EBV) Infection by Synergistic Action of Rituximab and Dexamethasone Renders EBV-Positive Lymphoma Cells More Susceptible to Ganciclovir Cytotoxicity In Vitro and In Vivo J. Virol., May 1, 2005; 79(9): 5875 - 5879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hong, H.-J. Delecluse, H. Gruffat, T. E. Morrison, W.-H. Feng, A. Sergeant, and S. C. Kenney The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1 J. Virol., May 15, 2004; 78(10): 4983 - 4992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Y. Wu, S. E. Wang, H. Chen, L. Wang, S. D. Hayward, and G. S. Hayward CCAAT/Enhancer Binding Protein {alpha} Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs during Induction of the EBV Lytic Cycle J. Virol., May 1, 2004; 78(9): 4847 - 4865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kudoh, M. Fujita, T. Kiyono, K. Kuzushima, Y. Sugaya, S. Izuta, Y. Nishiyama, and T. Tsurumi Reactivation of Lytic Replication from B Cells Latently Infected with Epstein-Barr Virus Occurs with High S-Phase Cyclin-Dependent Kinase Activity while Inhibiting Cellular DNA Replication J. Virol., January 15, 2003; 77(2): 851 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Miller Jr. and A. El-Guindy Regulation of Epstein-Barr Virus Lytic Cycle Activation in Malignant and Nonmalignant Disease J Natl Cancer Inst, December 4, 2002; 94(23): 1733 - 1735. [Full Text] [PDF]
|
|
|
|
|
|
W.-h. Feng, E. Westphal, A. Mauser, N. Raab-Traub, M. L. Gulley, P. Busson, and S. C. Kenney Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors J. Virol., November 1, 2002; 76(21): 10951 - 10959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gruffat, J. Batisse, D. Pich, B. Neuhierl, E. Manet, W. Hammerschmidt, and A. Sergeant Epstein-Barr Virus mRNA Export Factor EB2 Is Essential for Production of Infectious Virus J. Virol., October 1, 2002; 76(19): 9635 - 9644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Niller, D. Salamon, J. Uhlig, S. Ranf, M. Granz, F. Schwarzmann, H. Wolf, and J. Minarovits Nucleoprotein Structure of Immediate-Early Promoters Zp and Rp and of oriLyt of Latent Epstein-Barr Virus Genomes J. Virol., April 15, 2002; 76(8): 4113 - 4118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-h. Feng, B. Israel, N. Raab-Traub, P. Busson, and S. C. Kenney Chemotherapy Induces Lytic EBV Replication and Confers Ganciclovir Susceptibility to EBV-positive Epithelial Cell Tumors Cancer Res., March 1, 2002; 62(6): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Darr, A. Mauser, and S. Kenney Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase Activation J. Virol., July 1, 2001; 75(13): 6135 - 6142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Swenson, E. Holley-Guthrie, and S. C. Kenney Epstein-Barr Virus Immediate-Early Protein BRLF1 Interacts with CBP, Promoting Enhanced BRLF1 Transactivation J. Virol., July 1, 2001; 75(13): 6228 - 6234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ragoczy and G. Miller Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites J. Virol., June 1, 2001; 75(11): 5240 - 5251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Segouffin-Cariou, G. Farjot, A. Sergeant, and H. Gruffat Characterization of the Epstein-Barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1 J. Gen. Virol., July 1, 2000; 81(7): 1791 - 1799. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Adamson, D. Darr, E. Holley-Guthrie, R. A. Johnson, A. Mauser, J. Swenson, and S. Kenney Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases J. Virol., February 1, 2000; 74(3): 1224 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Jenkins, U. K. Binne, and P. J. Farrell Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency J. Virol., January 15, 2000; 74(2): 710 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ragoczy and G. Miller Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes J. Virol., December 1, 1999; 73(12): 9858 - 9866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lukac, J. R. Kirshner, and D. Ganem Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi's Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells J. Virol., November 1, 1999; 73(11): 9348 - 9361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Francis, T. Ragoczy, L. Gradoville, L. Heston, A. El-Guindy, Y. Endo, and G. Miller Amino Acid Substitutions Reveal Distinct Functions of Serine 186 of the ZEBRA Protein in Activation of Early Lytic Cycle Genes and Synergy with the Epstein-Barr Virus R Transactivator J. Virol., June 1, 1999; 73(6): 4543 - 4551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ragoczy, L. Heston, and G. Miller The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes J. Virol., October 1, 1998; 72(10): 7978 - 7984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-J. Chang, Y.-S. Chang, and S.-T. Liu Role of Rta in the Translation of Bicistronic BZLF1 of Epstein-Barr Virus J. Virol., June 1, 1998; 72(6): 5128 - 5136. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
